ABSTRACT
The increasingly international nature of the pharmaceutical and chemical industry has
resulted in many common regulatory goals in the major national regulatory agencies
and development of multinational organizations, such as the Organization for Economic
Co-operation and Development (OECD) and the International Conference on
Harmonization (ICH), to reduce inconsistencies in regulatory burdens and reduce the
number of animals used unnecessarily in regulatory testing.